CARDINAL HEALTH INC (1CAH.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:1CAH - US14149Y1082 - Common Stock
178.1 EUR
+44 (+32.81%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 205.012B 13.04% | 226.827B 10.64% | 222.578B -1.87% | 256.541B 15.26% | 277.949B 8.34% | 299.225B 7.65% | 329.362B 10.07% | 352.653B 7.07% | |
| EBITDA YoY % growth | 2.466B 4.09% | 2.86B 15.98% | 3.273B 14.44% | 3.736B 14.15% | 4.079B 9.18% | 4.489B 10.05% | N/A | N/A | |
| EBIT YoY % growth | 1.774B 5.78% | 2.15B 21.20% | 2.483B 15.49% | 3.227B 29.96% | 3.533B 9.48% | 4.019B 13.76% | 4.446B 10.62% | 4.715B 6.05% | |
| Operating Margin | 0.87% | 0.95% | 1.12% | 1.26% | 1.27% | 1.34% | 1.35% | 1.34% | |
| EPS YoY % growth | 5.81 14.82% | 7.47 28.57% | 8.24 10.31% | 9.72 18.00% | 10.98 12.91% | 12.40 12.99% | 14.07 13.41% | 15.21 8.12% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.31 19.49% | 2.73 16.11% | 2.32 11.51% | 2.73 6.88% | 2.57 11.33% | 3.06 12.08% | 2.60 12.26% | 2.69 -1.42% | 2.67 3.86% | 3.22 5.35% | 2.96 13.65% |
| Revenue Q2Q % growth | 65.004B 17.62% | 62.941B 14.69% | 67.245B 11.78% | 69.477B 8.54% | 68.003B 4.61% | 66.607B 5.82% | 72.793B 8.25% | 68.292B -1.71% | 72.116B 6.05% | 74.927B 12.49% | 81.844B 12.43% |
| EBITDA Q2Q % growth | 909.94M -3.20% | 1.034B -21.19% | 911.39M -35.77% | 1.097B 9.26% | 990.71M 8.88% | 1.112B 7.54% | 1.022B 12.14% | 1.063B -3.10% | 1.059B 6.89% | 1.185B 6.56% | 1.114B 9.00% |
| EBIT Q2Q % growth | 808.35M 42.82% | 932.53M 27.57% | 797.43M 26.78% | 926.89M 20.22% | 869.23M 7.53% | 1.009B 8.20% | 859.85M 7.83% | 894.2M -3.53% | 908.69M 4.54% | 1.07B 6.05% | 957.79M 11.39% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 2.55 35.64% | 2.20 | 0.35 | 15.85% |
| Q4 2025 Q2Q % growth | 2.08 13.04% | 2.06 | 0.02 | 1.06% |
| Q3 2025 Q2Q % growth | 2.35 12.98% | 2.19 | 0.16 | 7.37% |
| Q2 2025 Q2Q % growth | 1.93 6.04% | 1.78 | 0.15 | 8.65% |
| Q1 2025 Q2Q % growth | 1.88 8.67% | 1.63 | 0.25 | 15.13% |
| Q4 2024 Q2Q % growth | 1.84 18.71% | 1.76 | 0.08 | 4.62% |
| Q3 2024 Q2Q % growth | 2.08 19.54% | 1.97 | 0.11 | 5.55% |
| Q2 2024 Q2Q % growth | 1.82 37.88% | 1.62 | 0.20 | 12.64% |
| Q1 2024 Q2Q % growth | 1.73 44.17% | 1.42 | 0.31 | 21.95% |
| Q4 2023 Q2Q % growth | 1.55 47.62% | 1.51 | 0.04 | 2.66% |
| Q3 2023 Q2Q % growth | 1.74 20.00% | 1.50 | 0.24 | 15.83% |
| Q2 2023 Q2Q % growth | 1.32 3.94% | 1.15 | 0.17 | 14.85% |
| Q1 2023 Q2Q % growth | 1.20 -6.98% | 0.95 | 0.25 | 26.10% |
| Q4 2022 Q2Q % growth | 1.05 -19.23% | 1.19 | -0.14 | -11.53% |
| Q3 2022 Q2Q % growth | 1.45 -5.23% | 1.54 | -0.09 | -5.87% |
| Q2 2022 Q2Q % growth | 1.27 -27.01% | 1.24 | 0.03 | 2.45% |
| Q1 2022 Q2Q % growth | 1.29 -14.57% | 1.34 | -0.05 | -3.68% |
| Q4 2021 Q2Q % growth | 1.30 25.00% | 1.21 | 0.09 | 7.29% |
| Q3 2021 Q2Q % growth | 1.53 -5.56% | 1.57 | -0.04 | -2.38% |
| Q2 2021 Q2Q % growth | 1.74 14.47% | 1.46 | 0.28 | 19.40% |
| Q1 2021 Q2Q % growth | 1.51 18.90% | 1.14 | 0.37 | 31.93% |
| Q4 2020 Q2Q % growth | 1.04 -6.31% | 0.93 | 0.11 | 12.43% |
| Q3 2020 Q2Q % growth | 1.62 1.89% | 1.45 | 0.17 | 11.94% |
| Q2 2020 Q2Q % growth | 1.52 17.83% | 1.23 | 0.29 | 23.28% |
| Q1 2020 Q2Q % growth | 1.27 -1.55% | 1.11 | 0.16 | 14.87% |
| Q4 2019 Q2Q % growth | 1.11 | 0.94 | 0.17 | 18.32% |
| Q3 2019 Q2Q % growth | 1.59 | 1.44 | 0.15 | 10.33% |
| Q2 2019 Q2Q % growth | 1.29 | 1.10 | 0.19 | 17.41% |
| Q1 2019 Q2Q % growth | 1.29 | 1.09 | 0.20 | 18.69% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 64.009B 22.44% | 59.789B | 4.22B | 7.06% |
| Q4 2025 Q2Q % growth | 60.159B 0.76% | 61.48B | -1.321B | -2.15% |
| Q3 2025 Q2Q % growth | 54.878B -0.06% | 55.907B | -1.029B | -1.84% |
| Q2 2025 Q2Q % growth | 55.264B -3.80% | 55.567B | -303M | -0.55% |
| Q1 2025 Q2Q % growth | 52.277B -4.34% | 51.404B | 873M | 1.70% |
| Q4 2024 Q2Q % growth | 59.708B 11.77% | 59.285B | 423M | 0.71% |
| Q3 2024 Q2Q % growth | 54.911B 8.76% | 56.615B | -1.704B | -3.01% |
| Q2 2024 Q2Q % growth | 57.445B 11.61% | 57.583B | -138M | -0.24% |
| Q1 2024 Q2Q % growth | 54.65B 10.17% | 55.306B | -656M | -1.19% |
| Q4 2023 Q2Q % growth | 53.42B 13.50% | 53.246B | 174M | 0.33% |
| Q3 2023 Q2Q % growth | 50.487B 12.60% | 50.206B | 281M | 0.56% |
| Q2 2023 Q2Q % growth | 51.469B 13.23% | 51.251B | 218M | 0.43% |
| Q1 2023 Q2Q % growth | 49.603B 12.82% | 48.668B | 935M | 1.92% |
| Q4 2022 Q2Q % growth | 47.065B 10.52% | 45.161B | 1.904B | 4.22% |
| Q3 2022 Q2Q % growth | 44.836B 14.16% | 43.591B | 1.245B | 2.86% |
| Q2 2022 Q2Q % growth | 45.457B 9.43% | 46.028B | -571M | -1.24% |
| Q1 2022 Q2Q % growth | 43.968B 12.55% | 42.352B | 1.616B | 3.82% |
| Q4 2021 Q2Q % growth | 42.586B 16.07% | 40.828B | 1.758B | 4.31% |
| Q3 2021 Q2Q % growth | 39.275B 0.30% | 40.494B | -1.219B | -3.01% |
| Q2 2021 Q2Q % growth | 41.541B 4.55% | 41.852B | -311M | -0.74% |
| Q1 2021 Q2Q % growth | 39.065B 4.62% | 38.559B | 506M | 1.31% |
| Q4 2020 Q2Q % growth | 36.689B -1.78% | 37.04B | -351M | -0.95% |
| Q3 2020 Q2Q % growth | 39.157B 11.15% | 37.316B | 1.841B | 4.93% |
| Q2 2020 Q2Q % growth | 39.735B 5.29% | 39.826B | -91M | -0.23% |
| Q1 2020 Q2Q % growth | 37.341B 6.04% | 37.115B | 226M | 0.61% |
| Q4 2019 Q2Q % growth | 37.353B | 37.183B | 170M | 0.46% |
| Q3 2019 Q2Q % growth | 35.228B | 35.547B | -319M | -0.90% |
| Q2 2019 Q2Q % growth | 37.74B | 36.46B | 1.28B | 3.51% |
| Q1 2019 Q2Q % growth | 35.213B | 33.991B | 1.222B | 3.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.18% | N/A | 2.03% | N/A |
| Revenue | 3.27% | N/A | 2.16% | N/A |